Logo image of XOMAO

XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO) Stock Fundamental Analysis

USA - NASDAQ:XOMAO - US98419J4040

25.28 USD
-0.04 (-0.16%)
Last: 11/4/2025, 12:40:26 PM
Fundamental Rating

4

XOMAO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 534 industry peers in the Biotechnology industry. There are concerns on the financial health of XOMAO while its profitability can be described as average. XOMAO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

XOMAO had negative earnings in the past year.
In the past year XOMAO has reported a negative cash flow from operations.
In multiple years XOMAO reported negative net income over the last 5 years.
In multiple years XOMAO reported negative operating cash flow during the last 5 years.
XOMAO Yearly Net Income VS EBIT VS OCF VS FCFXOMAO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

With an excellent Return On Assets value of -7.93%, XOMAO belongs to the best of the industry, outperforming 85.39% of the companies in the same industry.
Looking at the Return On Equity, with a value of -19.17%, XOMAO belongs to the top of the industry, outperforming 84.64% of the companies in the same industry.
With an excellent Return On Invested Capital value of 3.73%, XOMAO belongs to the best of the industry, outperforming 91.95% of the companies in the same industry.
Industry RankSector Rank
ROA -7.93%
ROE -19.17%
ROIC 3.73%
ROA(3y)-14.85%
ROA(5y)-6.52%
ROE(3y)-31.32%
ROE(5y)-15.58%
ROIC(3y)N/A
ROIC(5y)N/A
XOMAO Yearly ROA, ROE, ROICXOMAO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800 1K

1.3 Margins

XOMAO's Operating Margin of 21.23% is amongst the best of the industry. XOMAO outperforms 95.32% of its industry peers.
XOMAO does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 21.23%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XOMAO Yearly Profit, Operating, Gross MarginsXOMAO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so XOMAO is destroying value.
The number of shares outstanding for XOMAO has been increased compared to 1 year ago.
Compared to 5 years ago, XOMAO has more shares outstanding
Compared to 1 year ago, XOMAO has a worse debt to assets ratio.
XOMAO Yearly Shares OutstandingXOMAO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
XOMAO Yearly Total Debt VS Total AssetsXOMAO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -5.50, we must say that XOMAO is in the distress zone and has some risk of bankruptcy.
XOMAO's Altman-Z score of -5.50 is on the low side compared to the rest of the industry. XOMAO is outperformed by 62.55% of its industry peers.
A Debt/Equity ratio of 1.11 is on the high side and indicates that XOMAO has dependencies on debt financing.
XOMAO has a Debt to Equity ratio of 1.11. This is in the lower half of the industry: XOMAO underperforms 77.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF N/A
Altman-Z -5.5
ROIC/WACC0.42
WACC8.97%
XOMAO Yearly LT Debt VS Equity VS FCFXOMAO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 4.88 indicates that XOMAO has no problem at all paying its short term obligations.
XOMAO's Current ratio of 4.88 is in line compared to the rest of the industry. XOMAO outperforms 53.75% of its industry peers.
XOMAO has a Quick Ratio of 4.88. This indicates that XOMAO is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of XOMAO (4.88) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 4.88
Quick Ratio 4.88
XOMAO Yearly Current Assets VS Current LiabilitesXOMAO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

6

3. Growth

3.1 Past

XOMAO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.74%.
Looking at the last year, XOMAO shows a very strong growth in Revenue. The Revenue has grown by 168.71%.
The Revenue has been growing by 9.17% on average over the past years. This is quite good.
EPS 1Y (TTM)-38.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.62%
Revenue 1Y (TTM)168.71%
Revenue growth 3Y-9.28%
Revenue growth 5Y9.17%
Sales Q2Q%18.39%

3.2 Future

Based on estimates for the next years, XOMAO will show a very strong growth in Earnings Per Share. The EPS will grow by 37.32% on average per year.
XOMAO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 35.53% yearly.
EPS Next Y126.86%
EPS Next 2Y49.97%
EPS Next 3Y37.32%
EPS Next 5YN/A
Revenue Next Year85%
Revenue Next 2Y45.1%
Revenue Next 3Y35.53%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XOMAO Yearly Revenue VS EstimatesXOMAO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
XOMAO Yearly EPS VS EstimatesXOMAO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

4

4. Valuation

4.1 Price/Earnings Ratio

XOMAO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 49.25, which means the current valuation is very expensive for XOMAO.
XOMAO's Price/Forward Earnings ratio is rather cheap when compared to the industry. XOMAO is cheaper than 89.89% of the companies in the same industry.
XOMAO's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.53.
Industry RankSector Rank
PE N/A
Fwd PE 49.25
XOMAO Price Earnings VS Forward Price EarningsXOMAO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, XOMAO is valued cheaper than 92.51% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 29.87
XOMAO Per share dataXOMAO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XOMAO's earnings are expected to grow with 37.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.97%
EPS Next 3Y37.32%

5

5. Dividend

5.1 Amount

XOMAO has a Yearly Dividend Yield of 8.27%, which is a nice return.
XOMAO's Dividend Yield is rather good when compared to the industry average which is at 89.85. XOMAO pays more dividend than 99.81% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, XOMAO pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.27%

5.2 History

XOMAO has been paying a dividend for over 5 years, so it has already some track record.
XOMAO has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
XOMAO Yearly Dividends per shareXOMAO Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

The earnings of XOMAO are negative and hence is the payout ratio. XOMAO will probably not be able to sustain this dividend level.
DP-30.88%
EPS Next 2Y49.97%
EPS Next 3Y37.32%
XOMAO Yearly Income VS Free CF VS DividendXOMAO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

XOMA ROYALTY CORP - XOMA 8 3/8 PERP

NASDAQ:XOMAO (11/4/2025, 12:40:26 PM)

25.28

-0.04 (-0.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners68.05%
Inst Owner ChangeN/A
Ins Owners1.4%
Ins Owner ChangeN/A
Market Cap305.64M
Revenue(TTM)44.95M
Net Income(TTM)-17720000
Analysts82
Price Target52.19 (106.45%)
Short Float %0.01%
Short Ratio0.37
Dividend
Industry RankSector Rank
Dividend Yield 8.27%
Yearly Dividend0.47
Dividend Growth(5Y)N/A
DP-30.88%
Div Incr Years0
Div Non Decr Years3
Ex-Date10-03 2025-10-03 (0.52344)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)207.59%
Min EPS beat(2)119.7%
Max EPS beat(2)295.48%
EPS beat(4)2
Avg EPS beat(4)28.19%
Min EPS beat(4)-256.98%
Max EPS beat(4)295.48%
EPS beat(8)3
Avg EPS beat(8)57.63%
EPS beat(12)4
Avg EPS beat(12)26.41%
EPS beat(16)5
Avg EPS beat(16)-3.83%
Revenue beat(2)2
Avg Revenue beat(2)76.76%
Min Revenue beat(2)32.7%
Max Revenue beat(2)120.82%
Revenue beat(4)3
Avg Revenue beat(4)39.95%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)120.82%
Revenue beat(8)5
Avg Revenue beat(8)13.46%
Revenue beat(12)7
Avg Revenue beat(12)9.54%
Revenue beat(16)8
Avg Revenue beat(16)-1.84%
PT rev (1m)8.46%
PT rev (3m)-18.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)72.73%
EPS NY rev (1m)0%
EPS NY rev (3m)371.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)8.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)10.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 49.25
P/S 6.8
P/FCF N/A
P/OCF N/A
P/B 3.31
P/tB 6.5
EV/EBITDA 29.87
EPS(TTM)-1.54
EYN/A
EPS(NY)0.51
Fwd EY2.03%
FCF(TTM)-1.91
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS3.72
BVpS7.65
TBVpS3.89
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.93%
ROE -19.17%
ROCE 4.73%
ROIC 3.73%
ROICexc 6.38%
ROICexgc 10.37%
OM 21.23%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-14.85%
ROA(5y)-6.52%
ROE(3y)-31.32%
ROE(5y)-15.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF N/A
Debt/EBITDA 9.33
Cap/Depr 1425.07%
Cap/Sales 44.89%
Interest Coverage 0.78
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.88
Quick Ratio 4.88
Altman-Z -5.5
F-Score5
WACC8.97%
ROIC/WACC0.42
Cap/Depr(3y)7738.51%
Cap/Depr(5y)4653.1%
Cap/Sales(3y)108.05%
Cap/Sales(5y)64.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.62%
EPS Next Y126.86%
EPS Next 2Y49.97%
EPS Next 3Y37.32%
EPS Next 5YN/A
Revenue 1Y (TTM)168.71%
Revenue growth 3Y-9.28%
Revenue growth 5Y9.17%
Sales Q2Q%18.39%
Revenue Next Year85%
Revenue Next 2Y45.1%
Revenue Next 3Y35.53%
Revenue Next 5YN/A
EBIT growth 1Y141.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year177.34%
EBIT Next 3Y51.87%
EBIT Next 5YN/A
FCF growth 1Y34.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.47%
OCF growth 3YN/A
OCF growth 5YN/A

XOMA ROYALTY CORP - XOMA 8 3/8 PERP / XOMAO FAQ

What is the ChartMill fundamental rating of XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO) stock?

ChartMill assigns a fundamental rating of 4 / 10 to XOMAO.


What is the valuation status of XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO) stock?

ChartMill assigns a valuation rating of 4 / 10 to XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO). This can be considered as Fairly Valued.


Can you provide the profitability details for XOMA ROYALTY CORP - XOMA 8 3/8 PERP?

XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO) has a profitability rating of 4 / 10.


What is the earnings growth outlook for XOMA ROYALTY CORP - XOMA 8 3/8 PERP?

The Earnings per Share (EPS) of XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO) is expected to grow by 126.86% in the next year.


How sustainable is the dividend of XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO) stock?

The dividend rating of XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO) is 5 / 10 and the dividend payout ratio is -30.88%.